Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by the United States Foodamp;Drug Administration (U.S. FDA) for Regadenoson Injection

Related Keywords

Mumbai ,Maharashtra ,India ,Udaykumar Murthydeputy ,States Glenmark ,Iqviatm National Sales Perspectives ,United States Fooddrug Administration ,Glenmark Pharmaceuticals Limited ,Glenmark Pharmaceuticals Inc ,Company Rankings ,Astellas Us Inc ,United States ,Regadenoson Injection ,Single Dose Pre Filled Syringe ,Sales Perspectives ,Pharmaceuticals Limited ,Generics Bulletin ,Dow Jones Sustainability Index ,Corporate Sustainability ,Udaykumar Murthydeputy General Manager ,Us News ,Glenmark Pharmaceuticals ,Single ,Ose Pre ,Brand ,Company ,November ,Tentative ,World ,Tentative Approval ,